Skip to main content
. 2007 Oct 25;6(4):507–515. doi: 10.1093/ecam/nem144

Figure 2.

Figure 2.

Change from baseline (± 95% confidence intervals) in sum of symptom scores for the Nervoheel N and lorazepam groups, respectively, at the intermediate and the final examinations.